MET expression and copy number status in clear-cell renal cell carcinoma: prognostic value and potential predictive marker

Multiple targeted therapy for advanced clear-cell renal cell carcinoma (RCC) has substantially improved patient outcome, but complete remission is uncommon and many tumors eventually develop resistance. Mechanistic, preclinical, and early clinical data highlight c-Met / hepatocyte growth factor rece...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Macher-Goeppinger, Stephan, Keith, Martina, Endris, Volker, Penzel, Roland, Tagscherer, Katrin E., Pahernik, Sascha, Hohenfellner, Markus, Gardner, Humphrey, Grüllich, Carsten, Schirmacher, Peter, Roth, Wilfried
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2016
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5352033/
https://ncbi.nlm.nih.gov/pubmed/27894094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13540
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items